Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3273H | — |
Shingrix administration with an unapproved diluent; Shingrix administration with an unapproved diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong diluent used in a 58-year-old male patient who received Herpes zoster (Shingrix) (batch number 3273H, expiry date 31-MAR-2027) for prophylaxis. On 01-OCT-2025, the patient received Shingrix. On 01-OCT-2025, an unknown time after receiving Shingrix, the patient experienced wrong diluent used (Verbatim: Shingrix administration with an unapproved diluent) and inappropriate reconstitution technique (Verbatim: Shingrix administration with an unapproved diluent). The outcome of the wrong diluent used and inappropriate reconstitution technique were not applicable. Additional Information: GSK Receipt Date: 08-OCT-2025 A medical assistant wanted to get recommendations on the administration of Shingrix reconstituted with an unapproved diluent, but she was not sure which of two patients received it. Thus, the details of each patient were taken to file the Adverse Event report and the advice to communicate again with us if she had a confirmation of which of the two got it was given.